APA (7th ed.) Citation

de Castro-Suárez, N., Trame, M. N., Ramos-Suzarte, M., Dávalos, J. M., Bacallao-Mendez, R. A., Maceo-Sinabele, A. R., . . . Rodríguez-Vera, L. (2020). Semi-Mechanistic Pharmacokinetic Model to Guide the Dose Selection of Nimotuzumab in Patients with Autosomal Dominant Polycystic Kidney Disease. Pharmaceutics, 12(12), 1147. https://doi.org/10.3390/pharmaceutics12121147

Chicago Style (17th ed.) Citation

de Castro-Suárez, Niurys, Mirjam N. Trame, Mayra Ramos-Suzarte, José M. Dávalos, Raymed A. Bacallao-Mendez, Anaelys R. Maceo-Sinabele, Víctor Mangas-Sanjuán, Gledys Reynaldo-Fernández, and Leyanis Rodríguez-Vera. "Semi-Mechanistic Pharmacokinetic Model to Guide the Dose Selection of Nimotuzumab in Patients with Autosomal Dominant Polycystic Kidney Disease." Pharmaceutics 12, no. 12 (2020): 1147. https://doi.org/10.3390/pharmaceutics12121147.

MLA (9th ed.) Citation

de Castro-Suárez, Niurys, et al. "Semi-Mechanistic Pharmacokinetic Model to Guide the Dose Selection of Nimotuzumab in Patients with Autosomal Dominant Polycystic Kidney Disease." Pharmaceutics, vol. 12, no. 12, 2020, p. 1147, https://doi.org/10.3390/pharmaceutics12121147.